Evolution and management of de novo neoplasm post-liver transplantation: a 20-year experience from a single European centre - PubMed (original) (raw)

Evolution and management of de novo neoplasm post-liver transplantation: a 20-year experience from a single European centre

Gonzalo Sapisochin et al. Hepatol Int. 2011 Jun.

Abstract

Purpose: Survival post-liver transplantation (LT) has improved; however, patients are considered at the, risk of malignancy due to prolonged immunosuppression. The long-term outcome of patients developing de novo neoplasm (DN) at our centre was evaluated.

Methods: Between October 1988 and December 2007, 800 LT were performed in 742 patients. Patients were divided into two study periods according to the time of LT; first: October 1988-December 1995; second: January 1996-December 2007.

Results: After a mean follow-up of 5 ± 4.6 years, 71 DN (9.5%) were detected in 742 patients. The cumulative risk of DN development increased with the time from LT although no differences at 3, 5, and 10 years were found when first and second periods were compared (3, 7, 16% vs. 2, 4, 11%, respectively; p = 0.4). DN incidence was higher in the first compared with the second period (10.7 vs. 7.8%; p < 0.04); no significant differences were observed in mortality rate (50 vs. 27%; p = 0.052). Actuarial patient survival post-DN at 1, 3, and 5 years: 67, 48, 45% versus 82, 71, 65%, in the first versus second period, respectively, p < 0.04.

Conclusions: DN incidence has decreased in recent years; however, as survival post-LT increases, so does the incidence of DN. Surveillance programmes are necessary to diagnose DN at early stages.

PubMed Disclaimer

Figures

Fig. 1

Fig. 1

Cumulative risk of DN development

Fig. 2

Fig. 2

Actuarial patient survival according to study period

Fig. 3

Fig. 3

Survival after DN according to type of tumor

References

    1. Registro Español de Trasplante Hepático (RETH). Memoria 1984–2006. http://www.ont.es/RETH
    1. Penn I. The problem of cancer in organ transplant recipients: an overview. Transplant Sci. 1994;4:23–32. - PubMed
    1. Rabkin JM, la Melena V, Orloff SL, Corless CL, Rosen HR, Olyaei AJ. Late mortality after orthotopic liver transplantation. Am J Surg. 2001;181:475–479. doi: 10.1016/S0002-9610(01)00595-5. - DOI - PubMed
    1. Sheiner PA, Magliocca JF, Bodian CA, Kim-Schluger L, Altaca G, Guarrera SV, Emre S, Fishbein TM, Guy SR, Schwartz ME, Miller CM. Long-term medical complications in patients surviving >5 years after liver transplant. Transplantation. 2000;69:781–789. doi: 10.1097/00007890-200003150-00018. - DOI - PubMed
    1. Jain A, Reyes J, Kashyap R, Dodson SF, Demetris AJ, Ruppert K, Abu-Elmagd K, Marsh W, Madariaga J, Mazariegos G, Geller D, Bonham CA, Gayowski T, Cacciarelli T, Fontes P, Starzl TE, Fung JJ. Long-term survival after liver transplantation in 4000 consecutive patients at a single center. Ann Surg. 2000;232:490–500. doi: 10.1097/00000658-200010000-00004. - DOI - PMC - PubMed

LinkOut - more resources